ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

292
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
28 Feb 2020 08:27

Samsung C&T & Electronics Price Coupling Issue Amid New 3-Yr Shareholder Return Policy

Samsung C&T unveiled a new shareholder return policy for the next three years, FY20~FY22. It said that it would give out 60~70% of the dividend...

Logo
312 Views
Share
25 Feb 2020 17:36

Korea - Shorts Increase on Samsung Common and Pref Shares

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 21 February...

Logo
255 Views
Share
18 Feb 2020 17:44

Korea - AmoreCorp, LotteChem, KMW, Helixmith Shorts Increase; Covering on Shinhan, Semco, Samsung

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 14 February...

Logo
328 Views
Share
bullishSamsung C&T
14 Feb 2020 07:01

LJY's Drug Abuse Allegations on Samsung C&T Synthetic Stub Trade

Samsung family member is again at the center of attention for drug abuse allegations. Last year, it was Lee Bu-jin, Hotel Silla CEO. This time, her...

Logo
349 Views
Share
11 Feb 2020 18:48

Long/Short Stock Set Ups in Asia

The following are some compelling short and long stock ideas for trades in Asia with entry, stop and target levels which are run through in the...

Share
x